Innovating products with cutting-edge research
Pear Therapeutics conducts ongoing clinical trials to develop and evaluate innovative products across many indications.
Pear Therapeutics is currently registering participants with chronic insomnia for our DREAM study using Somryst™, a cognitive behavioral therapy for insomnia digital therapeutic. Complete this short form to become a subject of this study.
If you have a smartphone and would like to go through our screening process to determine eligibility, please complete this short form and we will email an invitation to begin screening. Invitations are typically sent within 10 days of completing the form. Please look for an email from Pear Therapeutics.
Want to learn more about Somryst and prescription digital therapeutics? Click here.
Eligible participants will have access to Somryst for 9 weeks and are eligible for compensation for completing post-assessments.